User profiles for S. Plevritis

Sylvia K. Plevritis

Professor of Biomedical Data Science, Stanford University
Verified email at stanford.edu
Cited by 23553

Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force

…, SS Han, EF Blom, DE Jonas, EJ Feuer, SK Plevritis… - Jama, 2021 - jamanetwork.com
Importance The US Preventive Services Task Force (USPSTF) is updating its 2013 lung cancer
screening guidelines, which recommend annual screening for adults aged 55 through 80 …

Risk-Based lung cancer screening: A systematic review

I Toumazis, M Bastani, SS Han, SK Plevritis - Lung cancer, 2020 - Elsevier
Lung cancer remains the leading cause of cancer related deaths worldwide. Lung cancer
screening using low-dose computed tomography (LDCT) has been shown to reduce lung …

Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review

JL Caswell-Jin, SK Plevritis, L Tian… - JNCI cancer …, 2018 - academic.oup.com
Background Metastatic breast cancer (MBC) treatment has changed substantially over time,
but we do not know whether survival post-metastasis has improved at the population level. …

The prognostic landscape of genes and infiltrating immune cells across human cancers

…, CD Hoang, M Diehn, RB West, SK Plevritis… - Nature medicine, 2015 - nature.com
Molecular profiles of tumors and tumor-associated cells hold great promise as biomarkers of
clinical outcomes. However, existing data sets are fragmented and difficult to analyze …

Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum

…, A Trejo, OI Ornatsky, RS Balderas, SK Plevritis… - Science, 2011 - science.org
Flow cytometry is an essential tool for dissecting the functional complexity of hematopoiesis.
We used single-cell “mass cytometry” to examine healthy human bone marrow, measuring …

[HTML][HTML] Effect of screening and adjuvant therapy on mortality from breast cancer

DA Berry, KA Cronin, SK Plevritis… - … England Journal of …, 2005 - Mass Medical Soc
Background We used modeling techniques to assess the relative and absolute
contributions of screening mammography and adjuvant treatment to the reduction in breast-cancer …

Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE

…, MD Linderman, K Sachs, GP Nolan, SK Plevritis - Nature …, 2011 - nature.com
The ability to analyze multiple single-cell parameters is critical for understanding cellular
heterogeneity. Despite recent advances in measurement technology, methods for analyzing …

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

…, H Huang, SJ Lee, M Munsell, SK Plevritis… - Annals of internal …, 2009 - acpjournals.org
… , but 3 (models E, S, and W) use tumor size and tumor growth. The models also differ by
whether treatment affects the hazard for death from breast cancer (models G, S, and D), results …

[HTML][HTML] Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

…, J Coller, SC Bendall, RJ Tibshirani, SK Plevritis… - Nature Medicine, 2022 - nature.com
Approximately 60% of patients with large B cell lymphoma treated with chimeric antigen
receptor (CAR) T cell therapies targeting CD19 experience disease progression, and …

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force

HJ De Koning, R Meza, SK Plevritis… - Annals of internal …, 2014 - acpjournals.org
Background: The optimum screening policy for lung cancer is unknown. Objective: To identify
efficient computed tomography (CT) screening scenarios in which relatively more lung …